Live tape
Top 8, mentions 7d7,587META2,272 mentions▲ +0.06GOOGL1,514 mentions▲ +0.02NVDA815 mentions▲ +0.09MUSE667 mentions▲ +0.07MSFT611 mentions▲ +0.06SPY579 mentions▲ +0.05QQQ567 mentions▲ +0.08TSLA562 mentions▲ +0.06

Equity · Technology

CLBT

Cellebrite DI Ltd. · NasdaqGS

$10.80 −5.14% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$18 $10 30 Jun 25 Sep

The line runs $14.61 on 30 June through $10.80 on 25 September, on a scale from $10 to $18. Days the market did not trade hold the previous close, flat.

The chart above plots the price of CLBT over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $14.61 on 30 June 2026 through $10.80 on 25 September 2026.

52-week range $10.45 – $19.56
Avg volume 221.2K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · as of Sep 25, 2026

CLBT insider trades

SEC Form 4 · last 90 days · newest reported trade 25 Aug 2026
Open-market buys 0
Open-market sells 9
Net sold $4.97M
Non-trade filings 6
Date Insider Type Shares Value
25 Aug 2026 Hogan Thomas E. Sell 25,299 $286K
24 Aug 2026 GEE DAVID NICHOLAS Chief Marketing Officer Sell 4,323 $49K
21 Aug 2026 GEE DAVID NICHOLAS Chief Marketing Officer Sell 2,198 $25K
21 Aug 2026 Jewell Marcus Global Chief Revenue Officer Sell 12,562 $141K
12 Aug 2026 GEE DAVID NICHOLAS Chief Marketing Officer Sell 230 $4K
12 Aug 2026 Jewell Marcus Global Chief Revenue Officer Sell 411 $7K
12 Aug 2026 Hogan Thomas E. Chief Executive Officer Sell 139,713 $2.15M
08 Jul 2026 Barter David Chief Financial Officer Sell 41,734 $683K
02 Jul 2026 Hogan Thomas E. Chief Executive Officer Sell 103,188 $1.63M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
24 Sep 2026 Ramji Shiven Chief Executive Officer Award 38,505
17 Sep 2026 Baudot-Trajtenberg Nadine Director Award 15,190
17 Sep 2026 Gruber Dafna Director Award 15,190
17 Sep 2026 Richardson Troy Director Award 15,190
17 Sep 2026 Van Buren Brandon Director Award 15,190
11 Aug 2026 Hogan Thomas E. Chief Executive Officer Award 339,484

CLBT reported financials

SEC EDGAR XBRL

CLBT reported revenue of $475.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was $78.3M.

Figure Reported Period
Revenue $475.7M 31 Dec 2025 fiscal year
Net income $78.3M 31 Dec 2025 fiscal year
Diluted EPS $0.31 31 Dec 2025 fiscal year
Total assets $938.9M 31 Dec 2025 at period end
Total equity $484.3M 31 Dec 2025 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025

CLBT institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a CLBT position for the quarter ended 30 Jun 2026 — a combined $44.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −24.8% shares 2,150,239 $31.4M
Citadel Advisors Trimmed −64.0% shares 517,144 $7.6M
ARK Investment Management Added +35.5% shares 170,923 $2.5M
Two Sigma Investments Trimmed −40.8% shares 137,336 $2.0M
Man Group New position 39,532 $577K
Point72 Asset Management New position 28,645 $418K
AQR Capital Management Trimmed −59.8% shares 13,712 $200K
Marshall Wace Exited

Source: SEC EDGAR 13F filings

CLBT fails-to-deliver

SEC CNS data

On 31 Aug 2026, 146 shares of CLBT failed to deliver (about $2K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Aug 2026 146 $2K <0.001%
28 Aug 2026 1,373 $17K 0.001%
24 Aug 2026 45,953 $508K 0.018%
17 Aug 2026 1,069 $12K <0.001%
14 Aug 2026 2,838 $31K 0.001%

Source: SEC fails-to-deliver (CNS) data